All In Biotech

Drug Trial Radar · NCT05637606

HIgh Versus STAndard Blood Pressure Target in Hypertensive High-risk Patients Undergoing Major Abdominal Surgery

HIgh Versus STAndard Blood Pressure Target in Hypertensive High-risk Patients: The HISTAP Randomized Clinical Trial.

Last checked: Nov 20, 2026Latest source record: Jun 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 636 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

636

Actual

Start

Mar 6, 2023

Primary completion

May 21, 2025

Study completion May 21, 2025

Sponsor

Lead sponsor
Humanitas Clinical and Research CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva
First posted
Dec 5, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a multicenter randomized controlled trial comparing two strategies of mean arterial blood pressure management (MAP ≥ 80mmHg vs MAP ≥ 65 mmHg) in high-risk surgical patients undergoing elective laparotomic/laparoscopic surgery.

Conditions

  • Blood Pressure
  • Complication,Postoperative
  • Intraoperative Hypotension

Interventions

  • EphedrineDrug

    In both the group, the target MAP can be maintained by means of bolus of ephedrine (2.5 mg). The maximal dose for the ephedrine allowed is 25 mg (10 boluses of 2.5 mg), after this threshold a continuous infusion of norepinephrine will be started

  • NorepinephrineDrug

    In both the group, the target MAP can be maintained by means of bolus of ephedrine (2.5 mg) or Etilefrine (1 mg). The continuous infusion of norepinephrine, as decided by the attending anesthetist, may be started at any point of the intraoperative period. The starting dose of norepinephrine is the lowest needed to reach the predefined MAP target.

  • Etilefrine Hydrochloride bolusDrug

    The maximal dose for the etilefrine allowed is 10 mg (10 boluses of 1 mg), after this threshold a continuous infusion of norepinephrine will be started

  • Use of pulse pressure and stroke volume variation (PPV and SVV); use of Mini Fluid Challenge (mini_FC)Diagnostic test

    PPV, SVV and mini\_FC will guide fluid bolus administration during an episode of intraoperative hypotension, following two predefined algorithms for laparotomic/non laparotomic surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite endpoint of postoperative mortality and at least one major organ dysfunction (see description in the secondary outcomes).Time frame: up to 30 days after operation

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Azienda Ospedaliero - Universitaria SS. Antonio e Biagio e Cesare Arrigo

    Alessandria, Italy

  • ASST Grande Ospedale Metropolitano Niguarda

    Milan, Italy

  • Istituto Nazionale dei Tumori

    Milan, Italy

  • Ospedale Antonio Cardarelli

    Naples, Italy

  • Azienda sanitaria Friuli Occidentale (AsFO]

    Pordenone, Italy

  • Ospedale Santo Stefano

    Prato, Italy

  • Ospedale S. Anna di Castelnovo ne' Monti

    Reggio Emilia, Italy

  • Sant'Eugenio ASL Roma 2:

    Roma, Italy

  • Azienda Ospedaliero Universitaria di Sassari

    Sassari, Italy

  • Ospedale Molinette

    Torino, Italy

  • Ospedale Santa Chiara di Trento

    Trento, Italy

  • Ospedali Riuniti Foggia- Università di Foggia

    Foggia, Apulia, Italy

  • Department of Anesthesia and Intensive Care, University Hospital of Modena

    Modena, Emilia-Romagna, Italy

  • Policlinico A. Gemelli

    Rome, Lazio, Italy

  • Humanitas Research Hospital

    Rozzano, MILANO, Italy

  • Fondazione Istituto San Raffaele G. Giglio

    Cefalù, Sicily, Italy

  • Careggi University Hospital

    Florence, Tuscany, Italy

  • Unit of Anesthesiology and Intensive Care B, Department of Surgery, Dentistry, Gynecology and Pediatrics, AOUI-University Hospital Integrated Trust of Verona

    Verona, Veneto, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.